Immune checkpoint inhibitors induce response in a dose-dependent manner while their immune related adverse events are dose-independent, a meta-analysis

被引：0
|
作者：
Rahma, Osama [1 ]
Reuss, Joshua [2 ]
Giobbie-Hurder, Anita [1 ]
Razavi, Ghazaleh [3 ]
Mehra, Pooja [4 ]
Gupta, Seema [5 ]
Elias, Rawad [6 ]
Khleif, Samir [5 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Georgia Canc Ctr, Augusta, GA USA
[4] Univ Virginia, Charlottesville, VA USA
[5] Georgetown Univ, Washington, DC USA
[6] Hartford Healthcare, Hartford, CT USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P265
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Association of Immune Checkpoint Inhibitors With Neurologic Adverse Events A Systematic Review and Meta-analysis
    Farooq, Muhammad Zain
    Aqeel, Sheeba Ba
    Lingamaneni, Prasanth
    Pichardo, Rayli Carolina
    Jawed, Aleeza
    Khalid, Saad
    Banskota, Shristi Upadhyay
    Fu, Pingfu
    Mangla, Ankit
    JAMA NETWORK OPEN, 2022, 5 (04) : E227722
  • [22] Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
    Tian, Jin-Cheng
    Liu, Hui
    Yan, Lun-Jie
    Ding, Zi-Niu
    Han, Cheng-Long
    Tian, Bao-Wen
    Tan, Si-Yu
    Dong, Zhao-Ru
    Wang, Dong-Xu
    Xue, Jun-Shuai
    Mao, Xin-Cheng
    Yan, Yu-Chuan
    Li, Tao
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2115 - 2129
  • [23] Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis
    Jin-Cheng Tian
    Hui Liu
    Lun-Jie Yan
    Zi-Niu Ding
    Cheng-Long Han
    Bao-Wen Tian
    Si-Yu Tan
    Zhao-Ru Dong
    Dong-Xu Wang
    Jun-Shuai Xue
    Xin-Cheng Mao
    Yu-Chuan Yan
    Tao Li
    Clinical and Experimental Medicine, 2023, 23 : 2115 - 2129
  • [24] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [25] Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors
    Zeng, Li
    Ma, Gang
    Chen, Kai
    Zhou, Qiao
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis
    Shen, Xin
    Yang, Jun
    Qian, Geng
    Sheng, Mingyu
    Wang, Yu
    Li, Guohui
    Yan, Jiaqing
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer
    Berti, Alvise
    Bortolotti, Roberto
    Dipasquale, Mariachiara
    Kinspergher, Stefania
    Prokop, Larry
    Grandi, Guido
    Inchiostro, Sandro
    Paolazzi, Giuseppe
    Caffo, Orazio
    Veccia, Antonello
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 162
  • [28] Immune-related adverse events as potential surrogates of immune checkpoint inhibitors' efficacy: a systematic review and meta-analysis of randomized studies
    Amoroso, V.
    Gallo, F.
    Alberti, A.
    Paloschi, D.
    Bravo, W. Ferrari
    Esposito, A.
    Cosentini, D.
    Grisanti, S.
    Pedersini, R.
    Petrelli, F.
    Berruti, A.
    ESMO OPEN, 2023, 8 (02)
  • [29] Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis
    Li, Shuluan
    Wang, Tianyu
    Lai, Wenjuan
    Zhang, Mingying
    Cheng, Boran
    Wang, Shubin
    Tong, Gangling
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (12) : 5150 - 5158
  • [30] Immune checkpoint inhibitors (ICI): A meta-analysis of immune-related adverse events (irAE) from cancer clinical trials.
    El Osta, Badi Edmond
    Hu, Fengjiao
    Sadek, Ramses F.
    Chintalapally, Rohini
    Tang, Shou-Ching
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345